 |
 |
Flex Wordle |
 |
Task 195 - FROWN, TOPOS, PAINS
Correct Answers: 1 - Total Answers: 2
Rules
Guess the Flex WORDLE in 3 tries. After each try, the color of the tiles will change to show how close your guess is to the solution.
If the tile becomes GREEN, your number or operation is located at correct place. If the tile becomes RED, your number or opeartion exists within the expression, but at different place.
Joke Of The Day
Fresh short jokes and puns
I suffer from kleptomania.
But when it gets really bad, I take something for it.
What did the duck say after she bought ChapStick?
Put it on my bill!
I’ve been bored recently, so I decided to take up fencing.
The neighbors keep demanding that I put it back.
RIP boiled water
you will be mist
What do Broad Street sprinters eat before a race?
Nothing.
They fast!
Why did the pony get sent to his room?
He wouldn’t stop horsing around!
What did one plate say to the other?
Dinner is on me!
What did the buffalo say to his son when he dropped him off at school?
"Bison!"
Can February March?
No, but April May.
I’m writing a book about glue.
I’m stuck on the first chapter.
I’m so good at sleeping,
I can do it with my eyes closed.
Why are spiders so smart?
They can find everything on the web.
Knock, knock. Who’s there?
Theodore.
Theodore who?
Theodore wasn’t opened so I knocked!
On This Day
Nathan KlineBorn 22 Mar 1916; died 11 Feb 1983 at age 66.Nathan Schellenberg Kline was an American psychiatrist who is credited with founding the field of psychopharmacology. In 1953, he began investigating the use of a new drug, reserpine, to treat schizophrenia. He continued to pioneer in the biochemical treatment of mentally ill patients by introducing the use of such drugs as the antidepressants lithium and iproniazid and the tranquilizer resperine. Because these drugs so successfully drugs treated two of the major categories of psychiatric illness, thousands of patients - formerly considered untreatable - were able to leave institutions and to rejoin society. By 1957, iproniazid, first in the class of monoamine oxidase (MAO) inhibitors, was treating an estimated 400,000 people in the U.S.« |
